T 1045/21 (Edaravone for treating ALS / MITSUBISHI TANABE) of 05.09.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T104521.20230905
- Date of decision
- 5 September 2023
- Case number
- T 1045/21
- Petition for review of
- -
- Application number
- 12830484.7
- IPC class
- A61P 25/28A61K 31/4152C07D 231/26
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 Art 056
- Application title
- MEDICINAL AGENT FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS OR PREVENTING PROGRESSION OF PHASE OF AMYOTROPHIC LATERAL SCLEROSIS
- Applicant name
- Mitsubishi Tanabe Pharma Corporation
- Opponent name
- Maiwald GmbH
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step - (no)
- Catchword
- -
- Citing cases
- T 0136/24
Order
For these reasons it is decided that:
The appeal is dismissed.